Skip to content

Wearable-guided physical activity coaching after first catheter ablation for atrial fibrillation: rationale and design of the randomized PA-in-AF feasibility trial

Wearable-guided physical activity coaching after first catheter ablation for atrial fibrillation: rationale and design of the randomized PA-in-AF feasibility trial - PA-in-AF feasibility trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00040804
Enrollment
90
Registered
2026-07-28
Start date
2026-08-17
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I48.1 I48.0

Interventions

Group 1: Arm 1 (Intervention to Promote Physical Activity Using Wearables): An intervention primarily delivered remotely to support physical activity (PA) through: monitoring via wearables, regular fe

Sponsors

Universitätsklinikum Regensburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: Atrial fibrillation with an indication for pulmonary vein isolation, ability and motivation to engage in physical activity, informed consent.

Exclusion criteria

Exclusion criteria: Previous pulmonary vein isolation, valve-related atrial fibrillation, overt heart failure with a left ventricular ejection fraction of 10 hours/week.

Design outcomes

Primary

MeasureTime frame
What: combined feasibility parameters (proportion of patients achieving PA targets, ratio of patients screened/randomized and randomized/analyzed). When: after the intervention phase (7 months). How: monitoring by wearable device.

Secondary

MeasureTime frame
Secondary feasibility objectives are to assess recruitment, randomization, retention, adherence to wearable monitoring, completeness of follow-up assessments, acceptability of the intervention, technical functionality of wearable data transfer, and safety of supported PA after AF ablation. Exploratory clinical and mechanistic objectives are to estimate the effect size and variability of the intervention on AF recurrence, AF burden, inflammatory biomarkers, cardiac structure and function, left atrial fibrosis, quality of life, and cardiovascular outcomes.

Countries

Germany

Contacts

Public ContactChristian Schach

Universitätsklinik Regensburg

christian.schach@ukr.de+49 941 944 17268

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026